Filing Details
- Accession Number:
- 0001209191-14-060592
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-01 17:16:38
- Reporting Period:
- 2014-09-30
- Filing Date:
- 2014-10-01
- Accepted Time:
- 2014-10-01 17:16:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1554979 | E Megan Pace | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp, Corp. Communications | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-09-30 | 1,172 | $38.80 | 24,522 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-09-30 | 5,625 | $51.75 | 30,147 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-09-30 | 3,532 | $37.86 | 33,679 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-09-30 | 15,250 | $48.74 | 48,929 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-09-30 | 17,157 | $45.11 | 66,086 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-09-30 | 6,875 | $83.36 | 72,961 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-09-30 | 6,875 | $77.31 | 79,836 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-09-30 | 7,576 | $111.32 | 72,260 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-09-30 | 21,881 | $112.21 | 50,379 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-09-30 | 15,400 | $113.08 | 34,979 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-09-30 | 11,629 | $113.90 | 23,350 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 1,172 | $0.00 | 1,172 | $38.80 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 5,625 | $0.00 | 5,625 | $51.75 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 3,532 | $0.00 | 3,532 | $37.86 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 15,250 | $0.00 | 15,250 | $48.74 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 17,157 | $0.00 | 17,157 | $45.11 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 6,875 | $0.00 | 6,875 | $83.36 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 6,875 | $0.00 | 6,875 | $77.31 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,344 | 2021-02-02 | No | 4 | M | Direct | |
1,875 | 2021-07-12 | No | 4 | M | Direct | |
4,218 | 2022-02-01 | No | 4 | M | Direct | |
15,250 | 2022-07-24 | No | 4 | M | Direct | |
28,593 | 2023-02-04 | No | 4 | M | Direct | |
20,625 | 2023-07-29 | No | 4 | M | Direct | |
48,125 | 2024-02-04 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $111.32 (range $110.61 to $111.60).
- Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $112.21 (range $111.61 to $112.60).
- Open market sales reported on this line occurred at a weighted average price of $113.08 (range $112.61 to $113.59).
- Open market sales reported on this line occurred at a weighted average price of $113.90 (range $113.62 to $114.32).
- The option vests in 16 quarterly installments from 02/03/2011.
- The option vests in 16 quarterly installments from 07/13/2011.
- The option vests in 16 quarterly installments from 02/02/2012.
- The option vests in 16 quarterly installments from 07/25/2012.
- The option vests in 16 quarterly installments from 02/05/2013.
- The option vests in 16 quarterly installments from 07/30/2013.
- The option vests in 16 quarterly installments from 02/05/2014.